Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.
Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.
Even if vaccines are as effective in the real world as they look in clinical trials, they can’t change the course of the pandemic overnight. We need reinforcements.
Shringla was speaking after handing over 2,000 vials of anti-virus drug Remdesivir to Nepal's Foreign Minister Pradeep Kumar Gyawali to help it contain the Covid pandemic.
The WHO’s thumbs-down on remdesivir highlights why the FDA has to do more than merely rubber-stamp Covid-19 treatments in the face of heavy White House pressure to move quickly.
WHO Friday advised against use of remdesivir for Covid because there’s ‘no evidence’ it improves survival, but doctors say it works on moderately ill patients.
WHO experts say their findings shouldn’t be interpreted to mean remdesivir is ineffective, but that there is no evidence it improves patient-important outcomes.
ICMR-NARI is body responsible for conducting WHO Solidarity trial in India, and its director Panda says remdesivir cannot be ruled out as a Covid treatment yet.
The results, published in NEJM, come weeks after WHO's Solidarity Trial concluded that remdesivir had little to no effect on hospitalised Covid patients.
Mamdani’s politics feels unusual compared to India’s current climate. He unapologetically foregrounds Muslim identity at a time when doing so in India invites scrutiny.
On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.
This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.
COMMENTS